HemaSphere (Jun 2022)

P905: IXAZOMIB-THALIDOMIDE-DEXAMETHASONE INDUCTION FOLLOWED BY IXAZOMIB OR PLACEBO MAINTENANCE IN NON-TRANSPLANT ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS; LONG-TERM RESULTS OF HOVON-126/NMSG 21.13

  • K. Groen,
  • M. R. Seefat,
  • B. van der Holt,
  • F. H. Schjesvold,
  • C. A. Stege,
  • M.-D. Levin,
  • M. Hansson,
  • R. B. Leys,
  • J. Regelink,
  • A. Waage,
  • D. Szatkowski,
  • P. Axelsson,
  • T. H. Do,
  • A. Svirskaite,
  • E. van der Spek,
  • E. Haukas,
  • D. Knut-Bojanowska,
  • P. F. Ypma,
  • C. Blimark,
  • U.-H. Mellqvist,
  • N. W. van de Donk,
  • P. Sonneveld,
  • A. Klostergaard,
  • A. J. Vangsted,
  • N. Abdilgaard,
  • S. Zweegman

DOI
https://doi.org/10.1097/01.HS9.0000846492.51234.76
Journal volume & issue
Vol. 6
pp. 796 – 797

Abstract

Read online

No abstracts available.